Of the consumer health products, the topical anesthetics are administered as sprays and gels. Psychological counseling and behavioral therapy are also used with mixed results. Off-label use of antidepressants and PDE-5 inhibitors have been used with limited success because of inconsistent efficacy and unacceptable side effects. There are no prescription products for PE approved by the U.S. PREBOOST is a proprietary OTC male genital desensitizer used for the treatment of PE. The condition is especially debilitating because many men who suffer from PE also report a significant impact on partners and relationships.Ībout PREBOOST ® / Roman Swipes (4% benzocaine wipes) Estimates of prevalence range significantly however, most experts estimate the prevalence rate at 20-30 percent of men, as it can affect men of all ages and it is the most commonly observed sexual disorder in men below 40 years of age. The ISSM defines PE as persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the person wishes it to happen. “We value our association with the leading men’s digital health clinic and our ability to increase patient access to this important medical product.”Īccording to the International Society for Sexual Medicine (ISSM), PE is the most common sexual dysfunction in men, even more common than erectile dysfunction. “We are pleased to extend our mutually successful partnership with Roman to provide a compelling, convenient and clinically-backed treatment for the many men who suffer from premature ejaculation,” said Mitchell Steiner, MD, Chairman, President and Chief Executive Officer of Veru Inc. This multi-million unit extension agreement extends the current three-year agreement for three more years. Roman successfully introduced Roman Swipes in mid-2018, which has seen rapid growth since its introduction. Roman has established itself as a leader in men’s digital health treatment, that brings the care of leading medical experts to the privacy of one's home. digital health distribution of the Company’s PREBOOST ®(4% benzocaine wipes) for the prevention of premature ejaculation (PE) under the Roman Swipes brand name. (NASDAQ: VERU), an oncology and urology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer and which uses profits from its sexual health business to help fund its biopharmaceutical clinical development programs, today announced that it has signed a three-year multi-million unit extension agreement with Roman, the digital men's health clinic, for Roman’s exclusive U.S. Roman Swipes Seeing Rapid Growth through Leading Men’s Digital Health Clinic. Three-Year Multi-Million Unit Extension Agreement –
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |